University of Cincinnati Academic Health Center

New Study Highlights Connection with Strawberries, Cognition and Mood in Middle-Aged, Overweight Adults

Retrieved on: 
Mercredi, novembre 8, 2023

WATSONSVILLE, Calif., Nov. 8, 2023 /PRNewswire/ -- A new study published in Nutrients shows daily consumption of strawberries for 12 weeks reduced interference in memory and depressive symptoms among middle-aged, overweight adults with self-reported mild cognitive decline.

Key Points: 
  • One group received a strawberry powder prepared from whole fruit that had been desiccated, freeze-dried and milled.
  • Daily servings of strawberry and control powder were sealed in packets for the convenience of the participants and to control daily dosage.
  • Participants were also asked to discontinue consumption of all berry fruits, juices and extracts for the duration of the study.
  • And, long-term observational studies, including the Health Professionals Study and the Nurses' Health Study, found that strawberry consumers had lower rates of cognitive decline," explains Christian.

Sarah Bush Lincoln Adopts DoseMe Precision Dosing Platform to Improve Overall Level of Patient Care

Retrieved on: 
Mercredi, septembre 13, 2023

DoseMe , a leading provider of precision dosing software for therapeutic drug monitoring (TDM) and creators of DoseMeRx and DoseMe Analytics, today announced Sarah Bush Lincoln utilized its precision dosing platform to transition to area under the curve (AUC) dosing for better patient care, upgrading DoseMeRx to integrate directly into their Cerner electronic health record (EHR).

Key Points: 
  • DoseMe , a leading provider of precision dosing software for therapeutic drug monitoring (TDM) and creators of DoseMeRx and DoseMe Analytics, today announced Sarah Bush Lincoln utilized its precision dosing platform to transition to area under the curve (AUC) dosing for better patient care, upgrading DoseMeRx to integrate directly into their Cerner electronic health record (EHR).
  • During drug development, drug level sampling at multiple time points helps define the relationship between drug administration and the AUC.
  • “DoseMeRx’s vancomycin model is the first phase of our precision dosing initiative with pediatric and obesity divisions to follow.
  • Sarah Bush Lincoln has 17 extended campus primary care locations and four walk-in clinics.

Mount Sinai Researchers Uncover How Mammary Glands Control Overall Energy Balance and Fat Metabolism

Retrieved on: 
Mercredi, juillet 26, 2023

NEW YORK, July 26, 2023 /PRNewswire-PRWeb/ -- An Icahn School of Medicine at Mount Sinai study sheds light on the intricate interplay between mammary adipose (fat) tissue and breast health, and offers exciting possibilities for understanding breast development, lactation, cancer, and obesity and related metabolic disorders.

Key Points: 
  • The researchers discovered a new family of locally secreted and locally acting molecules in the breast called "mammokines" that contribute not only to normal mammary biology, but to overall fat cell physiology and energy balance control.
  • Mammary adipocytes play important roles in organizing mammary ducts, and the reverse is true as well.
  • The new studies reveal an unexpected role for nerve-activated ductal cells in mammary adipocyte metabolism and heat generation.
  • These mammary duct-secreted mammokines play an important role in controlling mammary gland fat abundance and could potentially orchestrate critical processes involved in breast development, lactation, and overall whole-body metabolic regulation.

Henry Schein Congratulates Dr. Louis W. Sullivan for Receiving a 2023 National Humanism in Medicine Medal, Awarded by The Arnold P. Gold Foundation

Retrieved on: 
Lundi, juillet 10, 2023

Henry Schein, Inc. (Nasdaq: HSIC) today celebrates Dr. Louis W. Sullivan for receiving a 2023 National Humanism in Medicine Medal from The Arnold P. Gold Foundation.

Key Points: 
  • Henry Schein, Inc. (Nasdaq: HSIC) today celebrates Dr. Louis W. Sullivan for receiving a 2023 National Humanism in Medicine Medal from The Arnold P. Gold Foundation.
  • View the full release here: https://www.businesswire.com/news/home/20230707576139/en/
    Dr. Louis W. Sullivan receives a 2023 National Humanism in Medicine Medal, awarded by The Arnold P. Gold Foundation (Photo: Business Wire)
    Medal recipients were recognized during The Gold Foundation’s Annual Gala held at the Ziegfeld Ballroom in New York City on June 20, 2023.
  • “For more than 16 years, we’ve been privileged to advance health equity and empower health care professionals through our work together at Henry Schein and the Henry Schein Cares Foundation.
  • Henry Schein co-founded The Gold Foundation’s Corporate Council in 2017, and Allison Neale, Henry Schein’s Vice President of Public Policy and Managing Director of the Henry Schein Cares Foundation, serves as the Council’s Chair.

AAMC Deeply Disappointed by SCOTUS Decision on Race-Conscious Admissions

Retrieved on: 
Jeudi, juin 29, 2023

The AAMC, informed by decades of research, recognizes the undeniable benefits of diversity for improving the health of people everywhere.

Key Points: 
  • The AAMC, informed by decades of research, recognizes the undeniable benefits of diversity for improving the health of people everywhere.
  • We will work together to adapt following today's court decision without compromising these goals.
  • For more information on the impact of race-conscious admissions on medical education, visit aamc.org/SCOTUSadmissions .
  • The AAMC (Association of American Medical Colleges) is a nonprofit association dedicated to improving the health of people everywhere through medical education, health care, medical research, and community collaborations.

KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology

Retrieved on: 
Lundi, juin 12, 2023

KalVista is currently assessing sebetralstat as an oral, short-term prophylaxis in KONFIDENT-S, the two-year open-label extension study for the KONFIDENT phase 3 trial.

Key Points: 
  • KalVista is currently assessing sebetralstat as an oral, short-term prophylaxis in KONFIDENT-S, the two-year open-label extension study for the KONFIDENT phase 3 trial.
  • The first of these describes the persisting burden of HAE on patients in their attempt to live normally.
  • “We also see that even in the context of modern prophylaxis, there remains a significant persisting burden for people living with HAE.
  • These findings highlight gaps in the existing HAE treatments and potentially position sebetralstat to address these unmet needs in this therapeutic landscape.”

Trepp Announces The Winners of Inaugural Scholarship Award

Retrieved on: 
Jeudi, mai 25, 2023

NEW YORK, May 25, 2023 /PRNewswire-PRWeb/ -- Trepp, a leading provider Trepp, a leading provider of data, insights, and technology solutions to structured finance, commercial real estate, and banking markets, announced today the winner of its 2023 Scholarship Award. Trepp awarded John "Jack" Walsh, a rising senior studying to earn a bachelor's in business administration with a focus in Finance, and Real Estate from the University of Cincinnati's Carl H. Linder College of Business, the $10,000 Trepp Scholarship Award, to go toward tuition assistance.

Key Points: 
  • Trepp has announced Jack Walsh of the University of Cincinnati and Mohammed Wara of New York University – Schack Institute of Real Estate, the winners of the inaugural 2023 Trepp Education Scholarship Award.
  • NEW YORK, May 25, 2023 /PRNewswire-PRWeb/ -- Trepp, a leading provider Trepp, a leading provider of data, insights, and technology solutions to structured finance, commercial real estate, and banking markets, announced today the winner of its 2023 Scholarship Award.
  • Trepp awarded John "Jack" Walsh, a rising senior studying to earn a bachelor's in business administration with a focus in Finance, and Real Estate from the University of Cincinnati's Carl H. Linder College of Business, the $10,000 Trepp Scholarship Award, to go toward tuition assistance.
  • More than 50 applicants applied for the scholarship, leaving an arduous task to the Trepp Education Steering Committee to narrow down to six finalists.

Innovative CPR Learning Game by Cincinnati Children's to be Launched by Attainment Company

Retrieved on: 
Jeudi, avril 6, 2023

Performing CPR is a skill that most anyone can learn, yet most CPR courses are not designed for people with different learning needs.

Key Points: 
  • Performing CPR is a skill that most anyone can learn, yet most CPR courses are not designed for people with different learning needs.
  • That's why Cincinnati Children's created the CPR toolkit, called "CPR and AED Basics," to help people with learning challenges or disabilities master this important lifesaving skill, and Attainment Company secured the rights to bring it to market.
  • Read more about the innovation process in this Cincinnati Children's Inspire Magazine article at CPR kit - Inspire, June 2021 (cincinnatichildrens.org) .
  • Attainment Company, an educational product company dedicated to helping people with disabilities succeed in school, work and life, recognized the potential of this innovative game.

Advanced Fertility Care Welcomes Dr. Kurt Peterson to Their Reproductive Physician Team

Retrieved on: 
Jeudi, mars 2, 2023

PHOENIX, March 2, 2023 /PRNewswire/ -- Advanced Fertility Care, a part of the Pinnacle Fertility network, announced today the addition of Dr. Kurt Peterson, a double board-certified physician in reproductive endocrinology and infertility and obstetrics and gynecology, to its team of fertility specialists.

Key Points: 
  • PHOENIX, March 2, 2023 /PRNewswire/ -- Advanced Fertility Care, a part of the Pinnacle Fertility network, announced today the addition of Dr. Kurt Peterson, a double board-certified physician in reproductive endocrinology and infertility and obstetrics and gynecology, to its team of fertility specialists.
  • With a passion for helping families grow, Dr. Peterson brings a wealth of experience, expertise, and fluency in Spanish to Advanced Fertility Care.
  • "We are thrilled to have Dr. Peterson join our team and bring his expertise to our patients," said Dr. Nathanial Zoneraich, Chief Medical Officer of Advanced Fertility Care.
  • Dr. Peterson is now accepting new patients at Advanced Fertility Care.

KalVista Pharmaceuticals Presents Data at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting

Retrieved on: 
Lundi, février 27, 2023

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today presented five posters at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San Antonio, Texas.

Key Points: 
  • KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today presented five posters at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San Antonio, Texas.
  • The following presentations occurred at the 2023 AAAAI Annual Meeting:
    A comparative bioavailability of sebetralstat following administration of orally disintegrating tablets and film-coated tablets in healthy volunteers: Michael D. Smith, KalVista Pharmaceuticals Inc., Cambridge, MA, USA
    Reporting of Adverse Drug Reactions with Parenteral Drugs for the On-Demand Treatment of Hereditary Angioedema Attacks – Analysis of the FAERS Database 2009 to 2022: Dr. Raffi Tachdjian, UCLA School of Medicine, Los Angeles, CA, USA
    Anxiety Associated With Parenteral On-Demand Treatment For Hereditary Angioedema (HAE): Dr.
  • Autumn Burnette, Division of Allergy and Immunology, Howard University Hospital, Washington, DC, USA
    Patient Perspectives On Early Use Of On-Demand Treatment For Hereditary Angioedema (HAE) Attacks to Reduce Severity and Duration: Dr. Cristine Radojicic, Division of Pulmonary, Allergy and Critical Care, Duke University Medical Center, Durham, North Carolina, USA
    Treatment with Sebetralstat Reduces the Cumulative Symptom Severity of Hereditary Angioedema Attacks in a Phase 2 Trial: Dr. Jonathan A. Bernstein, University of Cincinnati College of Medicine and Bernstein Clinical Research Center, LLC, Cincinnati, OH, USA
    “The real-world data presented at AAAAI highlight the significant treatment burden and anxiety associated with existing injectable on-demand therapies, and the potential for sebetralstat, an investigational oral plasma kallikrein inhibitor, to improve the treatment experience for people living with HAE,” said Andrew Crockett, Chief Executive Officer of KalVista.
  • “Additionally highlighting this potential are the data from our phase 2 trial assessing sebetralstat for on-demand of HAE attacks demonstrating that early treatment decreased cumulative attack and symptom severity compared to placebo, as well as new data supporting continued advancement of our orally disintegrating tablet formulation.”